JP2007515487A - カリウムイブプロフェンの高度に濃厚な注入可能水溶液、それらの調製及びそれらの使用 - Google Patents

カリウムイブプロフェンの高度に濃厚な注入可能水溶液、それらの調製及びそれらの使用 Download PDF

Info

Publication number
JP2007515487A
JP2007515487A JP2006547093A JP2006547093A JP2007515487A JP 2007515487 A JP2007515487 A JP 2007515487A JP 2006547093 A JP2006547093 A JP 2006547093A JP 2006547093 A JP2006547093 A JP 2006547093A JP 2007515487 A JP2007515487 A JP 2007515487A
Authority
JP
Japan
Prior art keywords
composition
ibuprofen
potassium
weight
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006547093A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007515487A5 (enExample
Inventor
フー，パトリク・シー
ランベス，グレゴリー・エイチ
マルコム，アーセリオ・ジエイ
Original Assignee
アルベマール・コーポレーシヨン
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アルベマール・コーポレーシヨン filed Critical アルベマール・コーポレーシヨン
Publication of JP2007515487A publication Critical patent/JP2007515487A/ja
Publication of JP2007515487A5 publication Critical patent/JP2007515487A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2006547093A 2003-12-22 2004-12-13 カリウムイブプロフェンの高度に濃厚な注入可能水溶液、それらの調製及びそれらの使用 Pending JP2007515487A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/744,545 US20050137262A1 (en) 2003-12-22 2003-12-22 Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
PCT/US2004/041584 WO2005065665A2 (en) 2003-12-22 2004-12-13 Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses

Publications (2)

Publication Number Publication Date
JP2007515487A true JP2007515487A (ja) 2007-06-14
JP2007515487A5 JP2007515487A5 (enExample) 2008-02-07

Family

ID=34678897

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006547093A Pending JP2007515487A (ja) 2003-12-22 2004-12-13 カリウムイブプロフェンの高度に濃厚な注入可能水溶液、それらの調製及びそれらの使用

Country Status (7)

Country Link
US (1) US20050137262A1 (enExample)
EP (2) EP1696891A2 (enExample)
JP (1) JP2007515487A (enExample)
KR (1) KR20060123378A (enExample)
CN (1) CN1897925A (enExample)
CA (1) CA2549731A1 (enExample)
WO (1) WO2005065665A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060088590A1 (en) * 2004-10-22 2006-04-27 Banner Pharmacaps, Inc. Non-blooming gelatin and non-gelatin formulations
US8231896B2 (en) 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system
WO2007035448A2 (en) * 2005-09-19 2007-03-29 Albemarle Corporation Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
BRPI0916344A2 (pt) * 2008-07-21 2020-07-21 Albemarle Corporation grânulos com alto teor de ibuprofeno de sódio, preparação e utilização para preparação de formas de dosagem sólidas não efervescentes
KR101599459B1 (ko) 2015-02-05 2016-03-14 주식회사 네오셈 반도체 소자 테스트 시스템 및 방법

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01502185A (ja) * 1986-10-17 1989-08-03 アール　ピー　シーラー　コーポレーション 医薬品のカプセル化の簡易化
JPH03502800A (ja) * 1988-03-25 1991-06-27 オラテク・ファーマセウティカル・デベロプメント・コーポレーション 水溶性イブプロフェン組成物及びその製造方法
JPH05310566A (ja) * 1991-12-19 1993-11-22 Rp Scherer Corp カプセルに封入する溶媒系
WO2003075909A1 (en) * 2002-03-11 2003-09-18 Warner-Lambert Company Llc Ibuprofen solution for hard shell capsules

Family Cites Families (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
DE2231426C3 (de) * 1972-06-27 1974-11-28 Motoren- Und Turbinen-Union Muenchen Gmbh, 8000 Muenchen Deckbandlose, innen gekühlte Axialturbinenlaufschaufel
US3987094A (en) * 1974-12-10 1976-10-19 The Upjohn Company Preparing carboxylic acids from glycidonitriles
US4189596A (en) * 1976-05-24 1980-02-19 The Upjohn Company Preparing 2-arylalkanoic acid derivatives
US4145440A (en) * 1977-08-18 1979-03-20 The Upjohn Company Liquid suspension of an aluminum salt of ibuprofen
IT1209145B (it) * 1979-11-23 1989-07-10 Resfar Srl Procedimento per migliorare le caratteristiche farmacologiche degli acidi aril-alcanoici adattivita' analgesica e anti-infiammatoria.
US4282252A (en) * 1980-05-15 1981-08-04 Thomas Jefferson University Method of increasing coronary blood flow with ibuprofen
US4346108A (en) * 1981-06-22 1982-08-24 The Upjohn Manufacturing Company M Method for preventing adhesion formation
US4447451A (en) * 1981-07-20 1984-05-08 The Upjohn Manufacturing Company M Treatment of adult respiratory distress syndrome
US4404210A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and ibuprofen
US4623736A (en) * 1982-07-09 1986-11-18 The Upjohn Company Arylalkanoic acid process improvement
US4447443A (en) * 1982-11-15 1984-05-08 Merck & Co., Inc. Anti-inflammatory/analgesic combination of α-fluoromethylhistidine and a selected non-steroidal anti-inflammatory drug (NSAID)
US4476248A (en) * 1983-02-28 1984-10-09 The Upjohn Company Crystallization of ibuprofen
US4439450A (en) * 1983-06-30 1984-03-27 The Upjohn Manufacturing Company M Treatment of the blood-brain barrier with ibuprofen
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
FR2573753B1 (fr) * 1984-11-29 1987-03-20 Sanofi Sa Procede de preparation d'a-hydroxy-acides et composes obtenus par ce procede
FR2573754B1 (fr) * 1984-11-29 1987-02-27 Sanofi Sa Procede de preparation d'acides a-hydroxyphenylalcanoiques et composes obtenus par ce procede
US4569937A (en) * 1985-02-11 1986-02-11 E. I. Du Pont De Nemours And Company Analgesic mixture of oxycodone and ibuprofen
CA1280414C (en) * 1985-03-15 1991-02-19 Saichi Matsumoto Isoprenoidamine derivatives and antiulcer agents
US4687662A (en) * 1985-08-30 1987-08-18 Warner-Lambert Company Therapeutic effervescent composition
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
JPH064561B2 (ja) * 1986-02-08 1994-01-19 日本石油化学株式会社 （置換アリ−ル）カルボン酸の製造方法
US4761274A (en) * 1986-03-27 1988-08-02 Warner-Lambert Company Medicament adsorbates of analgesics with complex magnesium aluminum silicate and their preparation
US4843099A (en) * 1987-07-20 1989-06-27 Colgate-Palmolive Company Device and composition for treatment of the gums
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
US5198568A (en) * 1988-04-07 1993-03-30 Sepracor, Inc. Compounds useful in enzymatic resolution systems and their preparation
EP0336031A1 (en) * 1988-04-07 1989-10-11 Council of Scientific and Industrial Research Process for the photochemical production of alpha-aryl propionic acid
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
US5007790A (en) * 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form
US5266723A (en) * 1989-05-16 1993-11-30 Medice, Ltd., Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg Process for the preparation of optically active 2-aryl-alkanoic acids, especially 2-aryl-propionic acids
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
US5015764A (en) * 1990-06-18 1991-05-14 Ethyl Corporation Preparation of optically active aliphatic carboxylic acids
US5183829A (en) * 1991-09-27 1993-02-02 Applied Analytical Industries, Inc. Oral liquid compositions of non-steroidal anti-inflammatory drugs
US5235100A (en) * 1992-01-24 1993-08-10 Ethyl Corporation Preparation of optically active aliphatic carboxylic acids
US5235101A (en) * 1992-01-24 1993-08-10 Ethyl Corporation Preparation by flotation of optically active aliphatic carboxylic acids
US5235095A (en) * 1992-01-24 1993-08-10 Ethyl Corporation Preparation of optically active aliphatic carboxylic acids
US5512300A (en) * 1992-09-15 1996-04-30 Warner-Lambert Company Prevention of ibuprofen from forming low melting eutectics with other therapeutic agents in solid dosage forms
US5278337A (en) * 1992-10-14 1994-01-11 Ethyl Corporation Enantiomeric resolution of aryl-substituted aliphatic carboxylic acids
US5248813A (en) * 1992-10-14 1993-09-28 Ethyl Corporation Enantiomeric resolution
ATE180668T1 (de) * 1992-12-01 1999-06-15 Spirig Ag S(+)-ibuprofen enthaltende arzneimittel
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
IT1272149B (it) * 1993-03-26 1997-06-11 Zambon Spa Composizione farmeceutiche ad attivita' analgesica
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica
US5866162A (en) * 1993-08-10 1999-02-02 Smithkline Beecham P.L.C. Pharmaceutical composition containing a drug/β-cyclodextrin complex in combination with an acid-base couple
US6149953A (en) * 1993-11-08 2000-11-21 Delta Food Group, Inc. Seeded microcapsules
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
US5616621A (en) * 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids
WO1996031218A1 (en) * 1995-04-03 1996-10-10 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition containing sucralfate
US6214386B1 (en) * 1995-11-22 2001-04-10 Recordati, S.A. Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
US5900416A (en) * 1996-02-01 1999-05-04 Anthea Enterprises Incorporated Aqueous caffeine dosage forms
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
US5827535A (en) * 1996-06-21 1998-10-27 Banner Pharmacaps, Inc. Graphically impressed softgel and method for making same
US5766622A (en) * 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
ATE197900T1 (de) * 1996-08-15 2000-12-15 Losan Pharma Gmbh Gut schluckbare orale arzneiform
US6767925B1 (en) * 1996-10-31 2004-07-27 Joseph A. Deihl Sprayable analgesic composition and method of use
US6472000B1 (en) * 1996-12-23 2002-10-29 Wm. Wrigley Jr. Co. Method of controlling release of bitterness inhibitors in chewing gum and gum produced thereby
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
US6071543A (en) * 1997-06-02 2000-06-06 Cellegy Pharmaceuticals, Inc. Pyridine-thiols reverse mucocutaneous aging
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US7303768B2 (en) * 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
US20030138499A1 (en) * 1998-12-17 2003-07-24 Shah Mandar V. Stable surgical irrigating solutions
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US6340473B1 (en) * 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6251426B1 (en) * 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
ES2288872T3 (es) * 1999-09-29 2008-02-01 R.P. Scherer Technologies, Inc. Granulaciones con celulosa hidrolizada de sales de medicamentos.
US20030124176A1 (en) * 1999-12-16 2003-07-03 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US6586000B2 (en) * 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
AU2001257511A1 (en) * 2000-05-03 2001-11-12 Joe D'silva Process and device for producing liquid dosage formulations
DE10027258C1 (de) * 2000-05-31 2001-10-31 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit okklusiver wirkstoffhaltiger Schicht und nicht-okklusiver Rückschicht
US20040022787A1 (en) * 2000-07-03 2004-02-05 Robert Cohen Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID
US6387400B1 (en) * 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
DE10103860B4 (de) * 2001-01-30 2004-12-23 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
ITRM20010048A1 (it) * 2001-01-30 2002-07-30 Gregorio Mauro De Metodo per preparare soluzioni acquose fisiologicamente accettabili esoluzioni cosi' ottenute.
CA2410469A1 (en) * 2001-03-27 2002-10-03 R.P. Scherer Technologies, Inc. Improved forms of pharmaceutically active agents and method for manufacture thereof
GB0108082D0 (en) * 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
US20020182600A1 (en) * 2001-04-11 2002-12-05 Smith Jack V. Method for assaying biological and other constituents using synthetic nucleounits in lateral flow, liquid, and dry chemistry techniques
US6551615B1 (en) * 2001-10-18 2003-04-22 M/S. Strides Arcolab Limited Dexibuprofen-containing soft gelatin capsules and process for preparing the same
US7004171B2 (en) * 2002-02-25 2006-02-28 Hi-Gienic Intra Vaginal Technologies Ltd. System for transvaginal drug delivery
WO2003099264A1 (en) * 2002-05-23 2003-12-04 Umd, Inc. Compositions and method for transmucosal drug delivery and cryoprotection
US20030022390A1 (en) * 2002-05-30 2003-01-30 Stephens James Matthew Method and kit for making interfering substances in urine undetectable
US7008763B2 (en) * 2002-09-23 2006-03-07 Cheung David T Method to treat collagenous connective tissue for implant remodeled by host cells into living tissue
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
US20040147534A1 (en) * 2003-01-23 2004-07-29 Foote Mary Ann Topical composition and method for treating occlusive wounds

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01502185A (ja) * 1986-10-17 1989-08-03 アール　ピー　シーラー　コーポレーション 医薬品のカプセル化の簡易化
JPH03502800A (ja) * 1988-03-25 1991-06-27 オラテク・ファーマセウティカル・デベロプメント・コーポレーション 水溶性イブプロフェン組成物及びその製造方法
JPH05310566A (ja) * 1991-12-19 1993-11-22 Rp Scherer Corp カプセルに封入する溶媒系
WO2003075909A1 (en) * 2002-03-11 2003-09-18 Warner-Lambert Company Llc Ibuprofen solution for hard shell capsules

Also Published As

Publication number Publication date
CA2549731A1 (en) 2005-07-21
US20050137262A1 (en) 2005-06-23
CN1897925A (zh) 2007-01-17
WO2005065665A3 (en) 2005-11-24
KR20060123378A (ko) 2006-12-01
EP1696891A2 (en) 2006-09-06
WO2005065665A2 (en) 2005-07-21
EP2156825A1 (en) 2010-02-24

Similar Documents

Publication Publication Date Title
CA2168732C (en) Gelatin capsules containing a highly concentrated acetaminophen solution
CA1177398A (en) Watersoluble derivatives of non-steroidal anti- inflammatory agents and a process for the production thereof
US20070224261A1 (en) Eutectic liquid drug formulation
JP2006514119A (ja) 溶解率が向上した難溶性薬剤の溶媒系
JPH01502185A (ja) 医薬品のカプセル化の簡易化
JP2004526664A (ja) 軟ゼラチン配合物とともに使用される薬学的組成物の調製方法
WO2009069139A1 (en) Dosage form providing an ibuprofen-containing liquid fill
WO1995031979A1 (en) Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
JP2001503372A (ja) 非ステロイド系抗炎症剤のゼラチンカプセルへの配合を目的とした安定な透明溶液
US5665384A (en) Oily capsules of ketoprofen
JP2007515487A (ja) カリウムイブプロフェンの高度に濃厚な注入可能水溶液、それらの調製及びそれらの使用
KR102397334B1 (ko) 2성분 조성물
US20100184870A1 (en) Long-term stable pharmaceutical preparation containing the active ingredient glycerol trinitrate
CA2466770C (en) Liquid pharmaceutical formulations of acetaminophen and an alkali metal 1-lactate salt
KR100612070B1 (ko) 용출률이 향상된 난용성 약제의 용매 시스템 및 이를 함유한 제약학적 제제
JP2007515487A5 (enExample)
US20100222291A1 (en) Medicinal forms of phospholipid preparations and methods for their preparation
JP2009508951A (ja) カリウムイブプロフェンの極めて濃厚な注入可能な水溶液、その製造法および使用
AU2014284294A1 (en) Capsule formulation comprising fexofenadine
KR101236528B1 (ko) 덱시부프로펜 액상 조성물을 함유하는 밀봉된 경질캡슐제
KR100201907B1 (ko) 비페닐디메틸디카르복실레이트를 가용화시킨 연질캅셀제
WO2023088976A1 (en) Orodispersible levothyroxine compositions
KR101346750B1 (ko) 나프록센 액상 조성물을 함유하는 밀봉된 경질캡슐제
JPH1112176A (ja) 安定なアスピリン軟膏製剤
WO2004047834A1 (en) Formulation and manufacturing process of solubilized aceclofenac soft capsules

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071212

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071212

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20080202

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110301

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110301

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110809

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110809